The more, the less: Age and chemotherapy load are predictive of poor stem cell mobilization in patients with hematologic malignancies

Chinese Medical Journal

Volumn 125, Issue 4, 2012, Pages 593-598

  Yang, Shen Miao ^a   Chen, Huan ^a   Chen, Yu Hong ^a   Zhu, Hong Hu ^a   Zhao, Ting ^a   Liu, Kai Yan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Chemotherapy; Granulocyte colony stimulating factor; Hematologic malignancies; Peripheral blood stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACUTE LEUKEMIA; ADULT; AGE; ARTICLE; BODY WEIGHT; CANCER REGRESSION; CD34 SELECTION; CONTROLLED STUDY; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INCIDENCE; LEUKAPHERESIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PATIENT CARE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION; RISK ASSESSMENT; RISK FACTOR; STEM CELL MOBILIZATION; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS;

ADULT; AGED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84863181959     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.04.007     Document Type: Article

References (43)

1. Koenigsmann M, Jentsch-Ullrich K, Mohren M, Becker E, Heim M, Franke A. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion 2004; 44: 777-784.
2. Perseghin P, Terruzzi E, Dassi M, Baldini V, Parma M, Coluccia P, et al. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three m ajor Italian institutions. Transfus Apher Sci 2009; 41: 33-37.
3. Sugrue MW, Williams K, Pollock BH, Khan S, Peracha S, Wingard JR, et al. Characterization and outcome of "hard to mobilize" lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000; 39: 509-519.
4. Micallef IN, Apostolidis J, Rohatiner AZ, Wiggins C, Crawley CR, Foran JM, et al. Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients w ith non-Hodgkin's lymphoma. Hematol J 2000; 1: 367-373.
5. Kuittinen T, Nousiainen T, Halonen P, Mahlamäki E, Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin' s lymphoma. Bone Marrow Transplant 2004; 33: 907-912.
6. + cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplant 2004; 33: 1083-1087.
7. Mendrone A Jr, Arrais CA, Saboya R, Chamone Dde A, Dulley FL. Factors affecting hematopoietic progenitor cell mobilization: an ana lysis of 307 patients. Transfus Apher Sci 2008; 39: 187-192.
8. Drake M, Ranaghan L, Morris TC, Nolan L, Desai ZR, Irvine AE, et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemot herapy scoring system. Br J Haematol 1997; 98: 745-749.
9. Lin JS, Burgstaler EA, Pineda AA, Gertz MA. Effects of whole blood flow rates on mononuclear cell yields during peripheral blood stem cell collecti on using Fenwal CS 3000 Plus. J Clin Apher 1995; 10: 7-11.
10. Ford CD, Pace N, Lehman C. Factors affecting the efficiency of collection of CD34-positive peripheral blood cells by a blood cell separator. Transfusion 1998; 38: 1046-1050.
11. Ikeda K, Ohto H, Nemoto K, Yamamoto G, Kato K, Ogata T, et al. Collection of MNCs and progenitor cells by two separators for PBPC transplantation: a randomized crossover trial. Transfusion 2003; 43: 814-819.
12. Adorno G, Del Proposto G, Palombi F, Bruno A, Ballatore G, Postorino M, et al. Collection of peripheral progenitor cells: a comparison between amicus and Cobe-spectra blood cell separators. Transfus Apher Sci 2004; 30: 131-136.
13. + cell determination by flow cytometry. International Society of Hematothe rapy and Graft Engineering. J Hematother 1996; 5: 213-226.
14. + cell dose in blood stem cell transplantatio n for cancer therapy. J Clin Oncol 2000; 18: 1360-1367.
15. + peripheral blood stem cells for an autologous transplant. Stem Cells Dev 2004; 13: 598-606.
16. + cells in patients with multiple myeloma. Results of the Spanish Myelo ma Group (GEM) Study. Haematologica 2006; 91: 621-627.
17. Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, et al. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurre nt or relapsed lymphoma. Am J Hematol 2009; 84: 335-337.
18. Fietz T, Rieger K, Dimeo F, Blau IW, Thiel E, Knauf WU. Stem cell mobilization in multiple myeloma patients: do we need an age-adjuste d regimen for the elderly? J Clin Apher 2004; 19: 202-207.
19. Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K, et al. Poor mobilization of hematopoietic stem cells: definitions, incidence, risk factors, and impact on outcome of autologous transpl antation. Biol Blood Marrow T ransplant 2010; 16: 490-499.
20. Tempescul A, Ianotto JC, Hardy E, Qiovoron F, Petroc L, Berthou C. Peripheral blood stem cell co llection in elderly pat ients. Ann Hematol 2010; 89: 317-321.
21. Laszlo D, Galieni P, Raspadori D, Tozzi M, Lauria F, Martinelli G. Fludarabine containing regimens may adversely affect peripheral blood stem cell collection in low grade lymphoma patients. Leuk Lymphoma 2000; 37: 157-161.
22. Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Fuadi SK, Gastineau DA, et al. Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with n ewly diagnosed mye loma. Leukemia 2007; 21: 2035-2042.
23. Popat U, Saliba R, Thandi R, Hosing C, Quazilbash M, Anderlini P, et al. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple mye loma. Biol Blood Marrow Transplant 2009; 15: 718-723.
24. Weaver CH, Birch R, Greco FA, Schwartzberg L, McAneny B, Moore M, et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of diff erent doses of filgrastim. Br J Haematol 1998; 100: 338-347.
25. Demirer T, Ayli M, Ozcan M, Gunel N, Haznedar R, Dagli M, et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of differe nt doses of rhG-CSF. Br J Haematol 200 2; 116: 468-474.
26. André M, Baudoux E, Bron D, Canon JL, D'Hondt V, Fassotte MF, et al. Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients wi th nonmyeloid malignancies. Transfusion 2003; 43: 50-57.
27. Crawford J, Caserta C, Roila F. ESMO Guidelines Working Group. Hematopoietic growth factors: ESMO clinical practice guid elines for the applications. Ann Oncol 2010; 21: v248-v251.
28. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006; 24: 3187-3205.
29. Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, et al. A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma. Haematologica 2006; 91: 550-553.
30. Mijovic A, Pamphilon D. Harvesting, processing and inventory management of peri pheral blood stem cells. Asian J Transfus Sci 2007; 1: 16-23.
31. Funes C, Garcia-Candel F, Majado MJ, González-García C, Bas A, Salido E, et al. Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for auto logous stem cell transplant. J Clin Apher 2010; 25: 223-225.
32. Masood N, Shaikh AJ, Memon WA, Idress R. Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature. Cases J 2008; 1: 418.
33. Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and revi ew of the literature. Haematologica 2006; 91: ECR08.
34. Kawachi Y, Watanabe A, Uchida T, Yoshizawa K, Kurooka N, Setsu K. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor. Br J Haematol 1996; 94: 413-416.
35. Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Biyikli Z, et al. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs. late administration of recombinant human G-CSF. Bone Marrow Transplant 2009; 44: 779-783.
36. Lefrère F, Audat F, Hermine O, Cavazzana-Calvo M, Belanger C, Arnulf B, et al. The timing of granulocyte- colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases. Transfusion 1999; 39: 561-564.
37. Zhang C, Chen X, Zhang X, Gao L, Kong P, Wang Q, et al. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex. Transfus Apher Sci 2008; 39: 21-28.
38. + cells in auto PBPCT. J Clin Apher 2009; 24: 232-237.
39. Lie AK, Rawling TP, Bayly JL, To LB. Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of hematopoietic growth factor and chemotherapy. Br J Haematol 1996; 95: 39-44.
40. Reiser M, Josting A, Draube A, Mapara MY, Scheid C, Chemnitz J, et al. Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization. Bone Marrow Transplant 1999; 23: 1223-1228.
41. Majado MJ, González C, Marín L, Morales A, Moya MR, Candel R. Second mobilization of peripheral blood progenitor cells in patients with poor first mobilization. Transplant Proc 2003; 35: 2027-2028.
42. Boeve S, Strupeck J, Creech S, Stiff PJ. Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Bone Marrow Transplant 2004; 33: 997-1003.
43. Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, et al. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant 2011; 46: 52-58.